Advertisement
Screener

T2 Biosystems, Inc. Forms 3, 4 and 5: Stock Options, 2018

T2 Biosystems, Inc. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2018-11-06: Reporting owner Lapidus Stanley; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2018-09-20: Reporting owner Lowery Thomas J.; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2018-09-20: Reporting owner Lowery Thomas J.; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
  • 2018-09-19: Reporting owner Lowery Thomas J.; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2018-11-06Lapidus Stanley
Director
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−27,058
0 owned after
$1.16
exercise price
2018-11-08
2018-09-20Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−31,603
0 owned after
$3.22
exercise price
2018-09-21
2018-09-20Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−16,602
0 owned after
$3.22
exercise price
2018-09-21
2018-09-19Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−10,403
0 owned after
$2.25
exercise price
2018-09-20
2018-09-19Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−27,499
31,603 owned after
$3.22
exercise price
2018-09-20
2018-09-18Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−14,647
0 owned after
$1.16
exercise price
2018-09-20
2018-09-18Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−18,588
0 owned after
$1.31
exercise price
2018-09-20
2018-09-18Lowery Thomas J.
Officer (Chief Scientific Officer)
4(Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−29,411
0 owned after
$1.96
exercise price
2018-09-20
2018-09-18Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−36,235
0 owned after
$2.45
exercise price
2018-09-20
2018-09-18Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3−1,361
10,403 owned after
$2.25
exercise price
2018-09-20
2018-06-12
holding as of filing
Jones Adrian M
Director
4Non-Qualified Stock Option (Right to Buy)
Derivative · Indirect · See footnotes
Holding
66,176 owned after
$8.92
exercise price
2018-06-12
2018-06-12
holding as of filing
GOLDMAN SACHS & CO. LLC | GOLDMAN SACHS GROUP INC
10% Owner | 10% Owner
4Non-Qualified Stock Option (Right to Buy)
Derivative · Indirect · See footnotes
Holding
66,176 owned after
$8.92
exercise price
2018-06-12
2018-03-14
holding as of filing
Barclay Alec
Officer (SVP, Operations)
3Stock Option
Derivative · Direct
Holding$9.32
exercise price
2018-03-14
2018-03-14
holding as of filing
Barclay Alec
Officer (SVP, Operations)
3Stock Option
Derivative · Direct
Holding$6.79
exercise price
2018-03-14
2018-03-14
holding as of filing
Barclay Alec
Officer (SVP, Operations)
3Stock Option
Derivative · Direct
Holding$5.19
exercise price
2018-03-14
2018-03-14
holding as of filing
Barclay Alec
Officer (SVP, Operations)
3Stock Option
Derivative · Direct
Holding$5.08
exercise price
2018-03-14
2018-03-01Lowery Thomas J.
Officer (Chief Scientific Officer)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+90,000
90,000 owned after
$5.08
exercise price
2018-03-12
2018-03-01McDonough John
Director, Officer (President and CEO)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+300,000
300,000 owned after
$5.08
exercise price
2018-03-12
2018-03-01Gibbs Michael Terrence
Officer (General Counsel)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+90,000
90,000 owned after
$5.08
exercise price
2018-03-12
2018-03-01Sprague John M
Officer (Chief Financial Officer)
4Stock Option (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+225,000
225,000 owned after
$5.08
exercise price
2018-03-02
2018-01-03
holding as of filing
Jones Adrian M
Director
4Non-Qualified Stock Option (Right to Buy)
Derivative · Indirect · See footnotes
Holding
66,176 owned after
$8.92
exercise price
2018-01-03
2018-01-03
holding as of filing
GOLDMAN SACHS GROUP INC | GOLDMAN SACHS & CO. LLC
10% Owner | 10% Owner
4Non-Qualified Stock Option (Right to Buy)
Derivative · Indirect · See footnotes
Holding
66,176 owned after
$8.92
exercise price
2018-01-03